← Eichor
Condition: Cannabidiol Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cannabidiol

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Modulation of THC Effects by CBD: a Dose-ranging Study
Phase 1/Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06099379MIVetsCan: Can-Coach Trial (Phase 2)
NA · 1 location(s) · University of Michigan · NCT06283862Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_Phase 1 · 1 location(s) · University of California, San Diego · NCT04883255Cannabidiol Into Breastmilk
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06589258MIVetsCan: Cannabidiol (CBD)-Care Trial
Phase 2 · 1 location(s) · Kevin Boehnke · NCT06213233Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Phase 1/Phase 2 · 1 location(s) · Staci Gruber, Ph.D. · NCT07728695Effects of Cannabidiol on Stress and Nicotine Withdrawal
Phase 1 · 1 location(s) · Johns Hopkins University · NCT07001930Cannabidiol for Bipolar Depression (CBD-BD)
Phase 3 · 6 location(s) · University of British Columbia · NCT05867849Cannabidiol (CBD) in Adults With ASD
Phase 1 · 1 location(s) · Johns Hopkins University · NCT05015439Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
NA · 1 location(s) · University of Minnesota · NCT07069478Alcohol Use Disorder and Cannabidiol
Phase 2/Phase 3 · 1 location(s) · University of Colorado, Denver · NCT05613608Cannabidiol Effects on Learning and Anxiety
EARLY_Phase 1 · 1 location(s) · University of Connecticut · NCT05283382Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach
Phase 3 · 1 location(s) · UMC Utrecht · NCT07668856The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Phase 2 · 1 location(s) · Bazelet Nehushtan LtD. · NCT06542445Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
Phase 2 · 1 location(s) · University of Nebraska · NCT05269459Study of Cannabidiol in Sanfilippo Syndrome
Phase 2/Phase 3 · 1 location(s) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA · NCT06333041Cannabidiol Medication Intervention Trial
Phase 2 · 5 location(s) · Sunnybrook Health Sciences Centre · NCT06014424Longitudinal Outpatient Treatment for Cannabis Use Disorder
Phase 2 · 1 location(s) · University of Colorado, Boulder · NCT06107062Cannabidiol for Reduction of Brain Neuroinflammation
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05066308CBD for Breast Cancer Primary Tumors
Phase 1 · 1 location(s) · Medical University of South Carolina · NCT06148038CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05410717Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
Phase 2 · 1 location(s) · Tiffany J. Braley, MD, MS · NCT05269628Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
Phase 2 · 2 location(s) · Chad Brummett · NCT06234631Cannabis' Impact on Alcohol Consumption
Phase 2 · 1 location(s) · Brown University · NCT05389930Cannabidiol and Cannabis Concentrate Users
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT06575751Oral Cannabidiol for Tobacco Cessation
Phase 1 · 1 location(s) · Johns Hopkins University · NCT05445804PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product
Phase 2 · 1 location(s) · Staci Gruber, Ph.D. · NCT03984565Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms
Phase 2 · 1 location(s) · Laboratorio Elea Phoenix S.A. · NCT06629389Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
Phase 2 · 1 location(s) · University of California, San Diego · NCT05514899Repeated CBD Administration and Cannabis Outcomes
EARLY_Phase 1 · 1 location(s) · Hannah Harris · NCT07434895
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.